MBX Biosciences, Inc.
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 36.08% | 14.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.81% | 9.73% | |||
| Operating Income | -7.81% | -9.73% | |||
| Income Before Tax | -2.05% | -11.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.05% | -11.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.05% | -11.37% | |||
| EBIT | -7.81% | -9.73% | |||
| EBITDA | -7.79% | -9.81% | |||
| EPS Basic | 22.37% | -8.91% | |||
| Normalized Basic EPS | 9.67% | -8.93% | |||
| EPS Diluted | 22.37% | -8.91% | |||
| Normalized Diluted EPS | 9.67% | -8.93% | |||
| Average Basic Shares Outstanding | 31.46% | 2.25% | |||
| Average Diluted Shares Outstanding | 31.46% | 2.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||